MeSH tree: D02.455.849.291.850
New research shows the idea of the "postcode lottery" was first used in 1997 to express concern about how access to National Health Service (NHS) drugs and treatment varied from place to place. But its meaning has since broadened ...
Oct 4, 2024
0
46
The 2023 cisplatin shortage led to a shift in utilization to alternative therapies for head and neck cancer (HNC), resulting in significant cost increases, according to a study presented at the American Society of Clinical ...
Oct 2, 2024
0
21
Scientists have discovered that a protein linked to prostate cancer is associated with more aggressive disease—it could be a new target for treatment and be used to help predict who will become resistant to hormone therapy.
Sep 18, 2024
0
70
Results from a clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) show a striking improvement for patients who received chemotherapy before surgery to remove advanced squamous cell-type cancer of the nose ...
Sep 10, 2024
0
31
A Phase III study comparing tusamitamab ravtansine with docetaxel in patients with advanced non-squamous non-small cell lung cancer (NSCLC) previously treated with platinum-based chemotherapy and immunotherapy (in combination ...
Sep 10, 2024
0
26
A new editorial paper titled "Targeting ABC transporters in PDAC—past, present, or future?" has been published in Oncotarget.
Jul 10, 2024
0
39
Many women treated for breast cancer using taxanes, a type of cytostatic drug, often experience side effects in the nervous system. Researchers at Linköping University have developed a tool that can predict the risk level ...
Jul 9, 2024
0
47
Black patients with early-stage breast cancer who were treated with docetaxel chemotherapy every 3 weeks had less drug-induced peripheral neuropathy and significantly fewer dose reductions compared to those who received weekly ...
Jun 4, 2024
0
31
A team of researchers has uncovered the identity of off-target cells responsible for abnormal outgrowth and devised a method to eliminate them from iPS cell-derived pancreatic tissues in development for cell therapy against ...
May 13, 2024
0
62
When doctors began using the drug sotorasib in 2021 with high expectations for its innovative approach to attacking lung cancer, retired medical technician Don Crosslin was an early beneficiary. Crosslin started the drug ...
May 9, 2024
0
51
